Portage Biotech Inc.
Portage Biotech Inc.
Indice CSE:
Devise:
Portage is engaged in researching and developing pharmaceutical and biotech products through to clinical "proof of concept" with an initial focus on unmet clinical needs and orphan drugs. Following proof of concept, Portage will look to sell or license the products to large pharmaceutical companies for further development and commercialization.
* TRADES IN USD *
Portage Biotech Inc. (PBT.U)
SEDAR Information
Information d'entreprise
Addresse
47 Avenue Road, Suite 200
Toronto, ON M5R 2G3
CanadaTéléphone
4169291806Fax
4169296612Courriel
ks@portagebiotech.comDate d’inscription à la cote
Lundi, octobre 28, 2013Capitalisation
Capitalisation:
10987706Réservé à l'émission:
5958Company Officers
Dr. Gregory Bailey, Chairman
Dr. Ian Walters, Chief Executive Officer
Allan Shaw, CFO
Bulletins
23/04/2021
2021-0438 - Delist - Portage Biotech Inc. (PBT.U)
le 23 avril/April 2021
At the request of the company the common shares of Portage Biotech Inc. will be delisted at market close on April 23, 2021.
The Company’s common shares will continue to trade on the NASDAQ Capital Market.
For further information please see the issuer’s press release.
___________________________
